- TEE
- Digoxin
- Thiazides
- Loop Diuretics
- K sparing Diuretics
- ACEI
- ARB
- DRI
- MRA
- Nitrate
- H-ISDN
- Class I AA
- BB
- Amiodarone
- Dronaderone
- Amlodipine
- Diltiazem
- Verapamil
- Ivabradine
- Nicorandil
- Ranolazine
- UFH
- LMWH
- OA
- APA
- Statins
- DCC
- AVN Abl.
- LV Cath. Abl.
- CRT
- ICD
- MV Surgery
- AV Surgery
- TV Surgery
- LV Surgery
- Myocardial Rev.
- LVAD/AH
- Heart transpl.
Class IIa indications for ivabradine therapy for reducing the risk of HF hospitalization:
- CHF + NYHA Class II - IV symptoms persisting despite treatment with ACEI and MRA and B-blocker + sinus rhythm + heart rate > 70 b.p.m. + LVEF < 35%,
- CHF + NYHA Class II - IV symptoms persisting despite treatment with ACEI and ARB and B-blocker +sinus rhythm + heart rate > 70 b.p.m. + LVEF < 35%,
- CHF + NYHA Class II - IV symptoms persisting despite treatment with ARB and MRA and B-blocker + sinus rhythm + heart rate > 70 b.p.m. + LVEF < 35%.
Class IIb indication for ivabradine therapy for reducing the risk of HF hospitalization:
- CHF + NYHA Class II - IV symptoms + sinus rhythm + heart rate > 70 b.p.m. + LVEF < 35% + poor tolerance of B-blockers.